Articles with public access mandates - Antonella D'Arminio MonforteLearn more
Not available anywhere: 6
Natural history of HIV-control since seroconversion
Y Madec, F Boufassa, K Porter, M Prins, C Sabin, AA Monforte, ...
Aids 27 (15), 2451-2460, 2013
Mandates: UK Medical Research Council
Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive highly active antiretroviral therapy
F Bai, GM Bellistrì, C Tincati, A Savoldi, A Pandolfo, T Bini, G Carpani, ...
AIDS 24 (16), 2590-2593, 2010
Mandates: US National Institutes of Health
Prevalence of prolonged amenorrhea in HIV-infected women: results from the Italian DIDI study
P Cicconi, A Ammassari, N Ladisa, F Di Sora, T Bini, P Pierro, G D'Ettorre, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 61 (2), e19-e21, 2012
Mandates: US National Institutes of Health, Doris Duke Charitable Foundation
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+ emtricitabine-containing HAART both in vivo and in vitro
C Alteri, M Surdo, VC Di Maio, F Di Santo, G Costa, L Parrotta, I Romeo, ...
Journal of Global Antimicrobial Resistance 7, 1-7, 2016
Mandates: Government of Italy
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men
J Hutchinson, B Neesgard, J Kowalska, K Grabmeier‐Pfistershammer, ...
HIV medicine, 2024
Mandates: National Health and Medical Research Council, Australia
Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test
M Zaccarelli, A Antinori, A Cozzi-Lepri, C Mussini, G Palamara, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (1), 150-151, 2010
Mandates: US National Institutes of Health
Available somewhere: 138
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
Antiretroviral Therapy Cohort Collaboration
The Lancet 372 (9635), 293-299, 2008
Mandates: Swiss National Science Foundation, US National Institutes of Health …
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
Mandates: Swiss National Science Foundation, US National Institutes of Health
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ...
The lancet HIV 4 (8), e349-e356, 2017
Mandates: Swiss National Science Foundation, US National Institutes of Health, US …
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ...
The Lancet 384 (9939), 241-248, 2014
Mandates: UK Medical Research Council
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse …
SW Worm, C Sabin, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ...
The Journal of infectious diseases 201 (3), 318-330, 2010
Mandates: Swiss National Science Foundation, US National Institutes of Health
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) study
S De Wit, CA Sabin, R Weber, SW Worm, P Reiss, C Cazanave, ...
Diabetes care 31 (6), 1224-1229, 2008
Mandates: Swiss National Science Foundation, US National Institutes of Health
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
Mandates: Swiss National Science Foundation, US National Institutes of Health
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study …
A Mocroft, JD Lundgren, ML Sabin, AA Monforte, N Brockmeyer, ...
PLoS medicine 10 (9), e1001510, 2013
Mandates: UK Medical Research Council
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ...
The Journal of infectious diseases 207 (9), 1359-1369, 2013
Mandates: Swiss National Science Foundation, US National Institutes of Health …
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D: A: D) study
N Friis-Møller, L Ryom, C Smith, R Weber, P Reiss, F Dabis, S De Wit, ...
European journal of preventive cardiology 23 (2), 214-223, 2016
Mandates: Swiss National Science Foundation, US National Institutes of Health …
Cardiovascular disease and use of contemporary protease inhibitors: the D: A: D international prospective multicohort study
L Ryom, JD Lundgren, W El-Sadr, P Reiss, O Kirk, M Law, A Phillips, ...
The lancet HIV 5 (6), e291-e300, 2018
Mandates: Swiss National Science Foundation, US National Institutes of Health, Danish …
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline …
A Mocroft, JD Lundgren, M Ross, CA Fux, P Reiss, O Moranne, P Morlat, ...
The lancet HIV 3 (1), e23-e32, 2016
Mandates: US National Institutes of Health
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients
SM Ingle, MT May, MJ Gill, MJ Mugavero, C Lewden, S Abgrall, ...
Clinical Infectious Diseases 59 (2), 287-297, 2014
Mandates: Swiss National Science Foundation, US National Institutes of Health …
Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery
FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ...
Clinical infectious diseases 58 (9), 1312-1321, 2014
Mandates: US National Institutes of Health, UK Medical Research Council
Publication and funding information is determined automatically by a computer program